{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:03:44Z","timestamp":1790831024103,"version":"4.1.0"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1117079"],"award-info":[{"award-number":["1117079"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["568807"],"award-info":[{"award-number":["568807"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001227","name":"Office of Health and Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001227","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008810","name":"NSW Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008810","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.bbi.2021.11.014","type":"journal-article","created":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T17:04:23Z","timestamp":1637341463000},"page":"423-434","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Peripheral complement is increased in schizophrenia and inversely related to cortical thickness"],"prefix":"10.1016","volume":"101","author":[{"given":"Ellen","family":"Ji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danny","family":"Boerrigter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen Q.","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Lloyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Bruggemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryanne","family":"O'Donnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cherrie","family":"Galletly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Lloyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhoshel","family":"Lenroot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas W.","family":"Weickert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Shannon Weickert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2021.11.014_b9005","unstructured":"American Psychiatric Association. (2000). Diagnostic and Statistical Manual of Mental Disorders (4th ed., text rev.)."},{"key":"10.1016\/j.bbi.2021.11.014_b0005","doi-asserted-by":"crossref","unstructured":"Al-Amin, M.M., M.M. Nasir Uddin, and H. Mahmud Reza, Effects of antipsychotics on the inflammatory response system of patients with schizophrenia in peripheral blood mononuclear cell cultures. Clin. Psychopharmacol. Neurosci. Off. Scient. J. Kor. Coll. Neuropsychopharmacol., 2013. 11(3): p. 144-151.","DOI":"10.9758\/cpn.2013.11.3.144"},{"issue":"5","key":"10.1016\/j.bbi.2021.11.014_b0010","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1177\/0004867415589793","article-title":"Cell proliferation is reduced in the hippocampus in schizophrenia","volume":"50","author":"Allen","year":"2016","journal-title":"Aust. N. Z. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.bbi.2021.11.014_b0015","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/npp.2017.164","article-title":"Complement Gene Expression Correlates with Superior Frontal Cortical Thickness in Humans","volume":"43","author":"Allswede","year":"2018","journal-title":"Neuropsychopharmacology"},{"issue":"11","key":"10.1016\/j.bbi.2021.11.014_b0020","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1176\/ajp.147.11.1457","article-title":"Auditory hallucinations and smaller superior temporal gyral volume in schizophrenia","volume":"147","author":"Barta","year":"1990","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.bbi.2021.11.014_b0025","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1176\/appi.ajp.2015.14101358","article-title":"Microglial Activity in People at Ultra High Risk of Psychosis and in Schizophrenia: An [11C]PBR28 PET Brain Imaging Study","volume":"173","author":"Bloomfield","year":"2016","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.bbi.2021.11.014_b0030","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-017-0962-y","article-title":"Using blood cytokine measures to define high inflammatory biotype of schizophrenia and schizoaffective disorder","volume":"14","author":"Boerrigter","year":"2017","journal-title":"J. Neuroinflammat."},{"issue":"9","key":"10.1016\/j.bbi.2021.11.014_b0035","doi-asserted-by":"crossref","first-page":"4419","DOI":"10.4049\/jimmunol.155.9.4419","article-title":"IFN-gamma up-regulates the human C5a receptor (CD88) in myeloblastic U937 cells and related cell lines","volume":"155","author":"Burg","year":"1995","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.bbi.2021.11.014_b0040","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/s41380-018-0235-x","article-title":"Increased macrophages and changed brain endothelial cell gene expression in the frontal cortex of people with schizophrenia displaying inflammation","volume":"25","author":"Cai","year":"2020","journal-title":"Mol. Psychiatry"},{"issue":"2","key":"10.1016\/j.bbi.2021.11.014_b0045","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.biopsych.2014.05.023","article-title":"Progressive reduction in cortical thickness as psychosis develops: a multisite longitudinal neuroimaging study of youth at elevated clinical risk","volume":"77","author":"Cannon","year":"2015","journal-title":"Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.bbi.2021.11.014_b0050","doi-asserted-by":"crossref","first-page":"e35511","DOI":"10.1371\/journal.pone.0035511","article-title":"Gene Expression Analysis Implicates a Death Receptor Pathway in Schizophrenia Pathology","volume":"7","author":"Catts","year":"2012","journal-title":"PLoS ONE"},{"issue":"8","key":"10.1016\/j.bbi.2021.11.014_b0055","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1177\/0004867419835028","article-title":"Adjunctive use of anti-inflammatory drugs for schizophrenia: A meta-analytic investigation of randomized controlled trials","volume":"53","author":"Cho","year":"2019","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.bbi.2021.11.014_b0250","unstructured":"Cleveland, W., Visualizing Data. AT&T Bell Laboratories, Murray Hill, New Jersey, 1993."},{"issue":"1","key":"10.1016\/j.bbi.2021.11.014_b0060","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1471-2172-10-52","article-title":"Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays","volume":"10","author":"de Jager","year":"2009","journal-title":"BMC Immunol."},{"issue":"1","key":"10.1016\/j.bbi.2021.11.014_b0065","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/cr.2009.139","article-title":"Complement and its role in innate and adaptive immune responses","volume":"20","author":"Dunkelberger","year":"2010","journal-title":"Cell Res."},{"issue":"2","key":"10.1016\/j.bbi.2021.11.014_b0070","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/mp.2012.110","article-title":"Increased inflammatory markers identified in the dorsolateral prefrontal cortex of individuals with schizophrenia","volume":"18","author":"Fillman","year":"2013","journal-title":"Mol. Psychiatry"},{"issue":"8","key":"10.1016\/j.bbi.2021.11.014_b0075","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1038\/mp.2015.90","article-title":"Elevated peripheral cytokines characterize a subgroup of people with schizophrenia displaying poor verbal fluency and reduced Broca's area volume","volume":"21","author":"Fillman","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbi.2021.11.014_b0080","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2020.00160","article-title":"The Role of Inflammation in the Treatment of Schizophrenia","volume":"11","author":"Fond","year":"2020","journal-title":"Front. Psychiatry"},{"issue":"11","key":"10.1016\/j.bbi.2021.11.014_b0085","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1038\/nn.4399","article-title":"Gene expression elucidates functional impact of polygenic risk for schizophrenia","volume":"19","author":"Fromer","year":"2016","journal-title":"Nat. Neurosci."},{"issue":"10","key":"10.1016\/j.bbi.2021.11.014_b0090","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/archpsyc.1997.01830220065010","article-title":"Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity","volume":"54","author":"Glantz","year":"1997","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1","key":"10.1016\/j.bbi.2021.11.014_b0095","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/archpsyc.57.1.65","article-title":"Decreased Dendritic Spine Density on Prefrontal Cortical Pyramidal Neurons in Schizophrenia","volume":"57","author":"Glantz","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1","key":"10.1016\/j.bbi.2021.11.014_b0100","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.neulet.2004.10.024","article-title":"Classical pathway complement activity in schizophrenia","volume":"374","author":"Hakobyan","year":"2005","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbi.2021.11.014_b0105","doi-asserted-by":"crossref","unstructured":"Hamdani, N., et al., Effects of Cumulative Herpesviridae and Toxoplasma gondii Infections on Cognitive Function in Healthy, Bipolar, and Schizophrenia Subjects. J. Clin. Psychiat., 2017. 78(1): p. e18-e27.","DOI":"10.4088\/JCP.15m10133"},{"issue":"1","key":"10.1016\/j.bbi.2021.11.014_b0110","doi-asserted-by":"crossref","first-page":"10","DOI":"10.9758\/cpn.2020.18.1.10","article-title":"Anti-inflammatory Strategies for Schizophrenia: A Review of Evidence for Therapeutic Applications and Drug Repurposing","volume":"18","author":"Hong","year":"2020","journal-title":"Clin. Psychopharmacol. Neurosci. Off. Scient. J. Kor. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.bbi.2021.11.014_b0115","doi-asserted-by":"crossref","unstructured":"International Schizophrenia, C., et al., Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature, 2009. 460(7256): p. 748-752.","DOI":"10.1038\/nature08185"},{"key":"10.1016\/j.bbi.2021.11.014_b0120","article-title":"Detailed Postmortem Profiling of Inflammatory Mediators Expression Revealed Post-inflammatory Alternation in the Superior Temporal Gyrus of Schizophrenia. Frontiers","volume":"12","author":"Izumi","year":"2021","journal-title":"Psychiatry"},{"key":"10.1016\/j.bbi.2021.11.014_b0125","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02230","article-title":"C-Reactive Protein: Higher During Acute Psychotic Episodes and Related to Cortical Thickness in Schizophrenia and Healthy Controls","volume":"9","author":"Jacomb","year":"2018","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.bbi.2021.11.014_b0130","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0006-3223(00)00988-4","article-title":"Cortical bcl-2 protein expression and apoptotic regulation in schizophrenia","volume":"48","author":"Jarskog","year":"2000","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.bbi.2021.11.014_b0135","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2332\/allergolint.O-07-527","article-title":"Activation of eosinophils by lipopolysaccharide-induced monocyte-derived cytokines","volume":"58","author":"Kobayashi","year":"2009","journal-title":"Allergol Int"},{"key":"10.1016\/j.bbi.2021.11.014_b0140","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.schres.2017.12.012","article-title":"Complement system biomarkers in first episode psychosis","volume":"204","author":"Kopczynska","year":"2019","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbi.2021.11.014_b0145","article-title":"The Role of Peripheral Inflammation in Clinical Outcome and Brain Imaging Abnormalities in Psychosis: A Systematic Review. Frontiers","volume":"12","author":"Kose","year":"2021","journal-title":"Psychiatry"},{"key":"10.1016\/j.bbi.2021.11.014_b0150","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.schres.2018.11.035","article-title":"Investigation of peripheral complement factors across stages of psychosis","volume":"204","author":"Laskaris","year":"2019","journal-title":"Schizophr. Res."},{"issue":"7","key":"10.1016\/j.bbi.2021.11.014_b0155","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.1038\/s41380-020-00914-0","article-title":"Multivariate relationships between peripheral inflammatory marker subtypes and cognitive and brain structural measures in psychosis","volume":"26","author":"Lizano","year":"2021","journal-title":"Mol. Psychiatry"},{"issue":"7","key":"10.1016\/j.bbi.2021.11.014_b0160","doi-asserted-by":"crossref","first-page":"3972","DOI":"10.4049\/jimmunol.167.7.3972","article-title":"Anaphylatoxin C5a actions in rat liver: synergistic enhancement by C5a of lipopolysaccharide-dependent alpha(2)-macroglobulin gene expression in hepatocytes via IL-6 release from Kupffer cells","volume":"167","author":"M\u00e4ck","year":"2001","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.bbi.2021.11.014_b0165","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2353\/ajpath.2007.070166","article-title":"The role of complement in inflammatory diseases from behind the scenes into the spotlight","volume":"171","author":"Markiewski","year":"2007","journal-title":"Am J. Pathol."},{"issue":"4","key":"10.1016\/j.bbi.2021.11.014_b0170","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1358\/dnp.2008.21.4.1213349","article-title":"The complement system in schizophrenia","volume":"21","author":"Mayilyan","year":"2008","journal-title":"Drug news & perspectives"},{"issue":"5","key":"10.1016\/j.bbi.2021.11.014_b0175","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.4049\/jimmunol.176.5.2950","article-title":"Evidence that complement protein C1q interacts with C-reactive protein through its globular head region","volume":"176","author":"McGrath","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbi.2021.11.014_b0180","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.schres.2018.01.018","article-title":"C4A mRNA expression in PBMCs predicts the presence and severity of delusions in schizophrenia and bipolar disorder with psychosis","volume":"197","author":"Melbourne","year":"2018","journal-title":"Schizophr. Res."},{"issue":"12","key":"10.1016\/j.bbi.2021.11.014_b0185","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.4088\/JCP.10m06745","article-title":"Stress and inflammation reduce brain-derived neurotrophic factor expression in first-episode psychosis: a pathway to smaller hippocampal volume","volume":"72","author":"Mondelli","year":"2011","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.bbi.2021.11.014_b0190","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.bbi.2020.01.014","article-title":"Baseline high levels of complement component 4 predict worse clinical outcome at 1-year follow-up in first-episode psychosis","volume":"88","author":"Mondelli","year":"2020","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.bbi.2021.11.014_b0195","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1001\/jamapsychiatry.2020.2459","article-title":"Development of Proteomic Prediction Models for Transition to Psychotic Disorder in the Clinical High-Risk State and Psychotic Experiences in Adolescence","volume":"78","author":"Mongan","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"12","key":"10.1016\/j.bbi.2021.11.014_b0200","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nrd4657","article-title":"Complement, a target for therapy in inflammatory and degenerative diseases","volume":"14","author":"Morgan","year":"2015","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"10.1016\/j.bbi.2021.11.014_b0205","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00406-021-01237-z","article-title":"Increased peripheral inflammation in schizophrenia is associated with worse cognitive performance and related cortical thickness reductions","volume":"271","author":"North","year":"2021","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.bbi.2021.11.014_b0210","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.psyneuen.2018.02.031","article-title":"Prevalence and correlates of low-grade systemic inflammation in adult psychiatric inpatients: An electronic health record-based study","volume":"91","author":"Osimo","year":"2018","journal-title":"Psychoneuroendocrinology"},{"issue":"4","key":"10.1016\/j.bbi.2021.11.014_b0215","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/s41380-018-0041-5","article-title":"Synaptic loss in schizophrenia: a meta-analysis and systematic review of synaptic protein and mRNA measures","volume":"24","author":"Osimo","year":"2019","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbi.2021.11.014_b0220","doi-asserted-by":"crossref","unstructured":"Perkins, D.O., et al., Towards a psychosis risk blood diagnostic for persons experiencing high-risk symptoms: preliminary results from the NAPLS project. Schizophren. Bull., 2015. 41(2): p. 419-428.","DOI":"10.1093\/schbul\/sbu099"},{"key":"10.1016\/j.bbi.2021.11.014_b0225","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.02002","article-title":"Increased Macrophages and C1qA, C3, C4 Transcripts in the Midbrain of People With Schizophrenia","volume":"11","author":"Purves-Tyson","year":"2020","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.bbi.2021.11.014_b0230","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1038\/sj.emboj.7601004","article-title":"Complement: a novel factor in basal and ischemia-induced neurogenesis","volume":"25","author":"Rahpeymai","year":"2006","journal-title":"The EMBO J."},{"issue":"5","key":"10.1016\/j.bbi.2021.11.014_b0235","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s00406-007-0733-3","article-title":"Neurogenesis and schizophrenia: dividing neurons in a divided mind?","volume":"257","author":"Reif","year":"2007","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"8","key":"10.1016\/j.bbi.2021.11.014_b0240","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41577-019-0168-x","article-title":"New insights into the immune functions of complement","volume":"19","author":"Reis","year":"2019","journal-title":"Nat. Rev. Immunol."},{"issue":"7510","key":"10.1016\/j.bbi.2021.11.014_b0245","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nature13595","article-title":"Corvin, A, Biological insights from 108 schizophrenia-associated genetic loci","volume":"511","author":"Ripke","year":"2014","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.bbi.2021.11.014_b0255","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/jnc.15241","article-title":"Trajectory of change in brain complement factors from neonatal to young adult humans","volume":"157","author":"Sager","year":"2021","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbi.2021.11.014_b0260","doi-asserted-by":"crossref","unstructured":"Schizophrenia Psychiatric Genome-Wide Association Study, C., Genome-wide association study identifies five new schizophrenia loci. Nature genetics, 2011. 43(10): p. 969-976.","DOI":"10.1038\/ng.940"},{"key":"10.1016\/j.bbi.2021.11.014_b0265","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.bbi.2020.04.021","article-title":"Increased densities of T and B lymphocytes indicate neuroinflammation in subgroups of schizophrenia and mood disorder patients","volume":"88","author":"Schlaaff","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2021.11.014_b0270","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nature16549","article-title":"Schizophrenia risk from complex variation of complement component 4","volume":"530","author":"Sekar","year":"2016","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.bbi.2021.11.014_b0275","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/s41593-018-0334-7","article-title":"Increased synapse elimination by microglia in schizophrenia patient-derived models of synaptic pruning","volume":"22","author":"Sellgren","year":"2019","journal-title":"Nat. Neurosci."},{"issue":"2-3","key":"10.1016\/j.bbi.2021.11.014_b0280","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0162-3109(99)00099-5","article-title":"The possible role of plasma kallikrein-kinin system and leukocyte elastase in pathogenesis of schizophrenia","volume":"43","author":"Shcherbakova","year":"1999","journal-title":"Immunopharmacology"},{"issue":"7256","key":"10.1016\/j.bbi.2021.11.014_b0285","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/nature08192","article-title":"Common variants on chromosome 6p22.1 are associated with schizophrenia","volume":"460","author":"Shi","year":"2009","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.bbi.2021.11.014_b0290","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1017\/S0033291700028397","article-title":"Reduced total complement haemolytic activity in schizophrenic patients","volume":"23","author":"Spivak","year":"1993","journal-title":"Psychol. Med."},{"issue":"7256","key":"10.1016\/j.bbi.2021.11.014_b0295","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/nature08186","article-title":"Common variants conferring risk of schizophrenia","volume":"460","author":"Stefansson","year":"2009","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.bbi.2021.11.014_b0300","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.cell.2007.10.036","article-title":"The classical complement cascade mediates CNS synapse elimination","volume":"131","author":"Stevens","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.bbi.2021.11.014_b0305","doi-asserted-by":"crossref","unstructured":"Sutterland, A.L., et al., Toxoplasma gondii Infection and Clinical Characteristics of Patients With Schizophrenia: A Systematic Review and Meta-analysis. Schizophr. Bullet. Open, 2020. 1(1).","DOI":"10.1093\/schizbullopen\/sgaa042"},{"key":"10.1016\/j.bbi.2021.11.014_b0310","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.bbi.2021.03.022","article-title":"Inflammatory cytokines, complement factor H and anhedonia in drug-na\u00efve major depressive disorder","volume":"95","author":"Tang","year":"2021","journal-title":"Brain Behav. Immun."},{"issue":"3","key":"10.1016\/j.bbi.2021.11.014_b0315","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1080\/13651501.2021.1927105","article-title":"Levels of lymphocyte-associated regulators of complement system CD55 and CD59 are changed in schizophrenia patients","volume":"25","author":"Togay","year":"2021","journal-title":"Int. J. Psych. Clin. Pract."},{"key":"10.1016\/j.bbi.2021.11.014_b0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopsych.2018.04.023","article-title":"Cortical Brain Abnormalities in 4474 Individuals With Schizophrenia and 5098 Control Subjects via the Enhancing Neuro Imaging Genetics Through Meta Analysis (ENIGMA) Consortium","author":"van Erp","year":"2018","journal-title":"Biol. Psychiatry"},{"issue":"9","key":"10.1016\/j.bbi.2021.11.014_b0325","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.biopsych.2018.04.023","article-title":"Cortical Brain Abnormalities in 4474 Individuals With Schizophrenia and 5098 Control Subjects via the Enhancing Neuro Imaging Genetics Through Meta Analysis (ENIGMA) Consortium","volume":"84","author":"van Erp","year":"2018","journal-title":"Biol. Psychiatry"},{"issue":"9","key":"10.1016\/j.bbi.2021.11.014_b0330","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1001\/archgenpsychiatry.2011.88","article-title":"Changes in Cortical Thickness During the Course of Illness in Schizophrenia","volume":"68","author":"van Haren","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.bbi.2021.11.014_b0335","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.nicl.2013.12.008","article-title":"Voxel-based gray and white matter morphometry correlates of hallucinations in schizophrenia: The superior temporal gyrus does not stand alone","volume":"4","author":"van Tol","year":"2014","journal-title":"Neuroimage Clin"},{"issue":"1","key":"10.1016\/j.bbi.2021.11.014_b0340","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1006\/exnr.1999.7199","article-title":"Cytokines associated with amyloid plaques in Alzheimer's disease brain stimulate human glial and neuronal cell cultures to secrete early complement proteins, but not C1-inhibitor","volume":"160","author":"Veerhuis","year":"1999","journal-title":"Exp. Neurol."},{"issue":"14","key":"10.1016\/j.bbi.2021.11.014_b0345","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1016\/j.molimm.2011.04.003","article-title":"Complement in the brain","volume":"48","author":"Veerhuis","year":"2011","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.bbi.2021.11.014_b0350","doi-asserted-by":"crossref","unstructured":"Weissleder, C., et al., Reduced Insulin-Like Growth Factor Family Member Expression Predicts Neurogenesis Marker Expression in the Subependymal Zone in Schizophrenia and Bipolar Disorder. Schizophr Bull, 2020.","DOI":"10.1093\/schbul\/sbaa159"},{"key":"10.1016\/j.bbi.2021.11.014_b0355","doi-asserted-by":"crossref","unstructured":"Weissleder, C., et al., Reduced adult neurogenesis is associated with increased macrophages in the subependymal zone in schizophrenia. Mol. Psych., 2021.","DOI":"10.1038\/s41380-021-01149-3"},{"issue":"1","key":"10.1016\/j.bbi.2021.11.014_b0360","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/s41380-019-0479-0","article-title":"The complement system in schizophrenia: where are we now and what's next?","volume":"25","author":"Woo","year":"2020","journal-title":"Mol. Psychiatry"},{"issue":"6","key":"10.1016\/j.bbi.2021.11.014_b9000","doi-asserted-by":"crossref","first-page":"663","DOI":"10.4088\/JCP.v64n0607","article-title":"Chlorpromazine equivalent doses for the newer atypical antipsychotics","volume":"64","author":"Woods","year":"2003","journal-title":"J. Clin. Psychiatry"},{"issue":"2-3","key":"10.1016\/j.bbi.2021.11.014_b0365","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.schres.2010.08.027","article-title":"The role of the insula in schizophrenia","volume":"123","author":"Wylie","year":"2010","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbi.2021.11.014_b0370","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.bbi.2016.04.009","article-title":"Cerebral complement C1q activation in chronic Toxoplasma infection","volume":"58","author":"Xiao","year":"2016","journal-title":"Brain Behav. Immun."}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159121006103?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159121006103?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T08:20:31Z","timestamp":1760170831000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159121006103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":76,"alternative-id":["S0889159121006103"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2021.11.014","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peripheral complement is increased in schizophrenia and inversely related to cortical thickness","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2021.11.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}